Hematology Meeting Reports (formerly Haematologica Reports)

Log In | Register

Archives

2009

Vol 3, No 5: 3rd International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin’s Lymphoma Frankfurt, Germany

Vol 3, No 4: 8th International Hereditary Hemorrhagic Telangiectasia Scientific Conference Santander. Spain, May 27-31, 2009

Vol 3, No 3: 7th Meeting New Insights in Hematology Venice, Italy, 26-29 April 2009

Vol 3, No 2: 9th International Winter Meeting on coaugulation Bormio (Sondrio), Italy, April 1-4, 2009

Vol 3, No 1: 2006...2009: Now we know T-cell lymphomas better, Bologna, Italy, 16-18 March 2009

2008

Vol 2, No 6: Corso educazionae lGITMO La terapia di condizionamento nel trapianto di cellule staminali emopoietiche

Vol 2, No 5: New Drugs in Hematology, Bologna, Italy 5-7 October 2008

Vol 2, No 4: Conférence du Club du Globule Rouge et du Fer, Les anemies génétiquement dèterminées, Brugge, Belgium, 25-27 September

Vol 2, No 3: The third Neutropenia Network ConfereneE, Iraklion, Crete, 26-27 September 2008

Vol 2, No 2: 5th International Symposium on Clinical Applications of Serum Free Light Chain AnalysiS, Bath, 17-19 September 2008

Vol 2, No 1: 8th International Winter Meeting on Coagulation

2007

Vol 1, No 7: Chronic Lymphocytic Leukemia: Achievements and Controversies

Vol 1, No 6: XXXIV Congresso Nazionale Società Italiana Ematologia Oncologia Pediatrica

Vol 1, No 5: Changing the paradigm: new perspectives in the treatment of haematological malignancies

Vol 1, No 4: Maintaining Life: Optimal Strategies to Improve Survival

Vol 1, No 3: von Willebrand disease: an update 80 years after its first description

Vol 1, No 2: Convegno dei centri di ematologia dell’Italia meridionale ed insulare

Vol 1, No 1: 7th Hereditary Hemorrhagic Telangiectasia International Scientific Conference

2006

Vol 2, No 15: Secondary Leukemias and leukemogenesis Rome, 3-4 November 2006

Vol 2, No 14: Immunomodulatory drugs: the foundation for treating hematological malignancies Amsterdam, 15 June 2006

Vol 2, No 13: It’s time to take care of T-Cell Lymphomas Bologna, Italy, 22-24 October 2006

Vol 2, No 12: Innovative Therapies for Lymphoid Malignancies Palermo (Italy), September 28 - October 1, 2006

Vol 2, No 11: A consensus and state-of-the-art workshop: Marrow ablative chemotherapy with Hematopoietic cell rescue for malignant Bra

Vol 2, No 10: Vth International Neonatal Hematology and Immunology Meeting

Vol 2, No 9: Associazione Italiana di Immunogenetica e Biologia dei Trapianti

Vol 2, No 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006

Vol 2, No 6: Malattie mieloproliferative croniche: policitemia, trombocitemia, mielofibrosi," Pavia, Italy, March 2006

Vol 2, No 5: Bortezomib (Velcade®) in multiple myeloma: an update

Vol 2, No 4: Coagulation. Basic, laboratory and clinical aspects of venous and arterial thromboembolic diseases", La Thuile, Italy, M

Vol 2, No 3: Cervo Preclinical Working Conference, Cervo Ligure, October 6-8, 2005

Vol 2, No 2: La terapia antifungina empirica in oncoematologia: criteri di scelta

Vol 2, No 1: Sistema nervoso centrale e malattie linfoproliferative

2005

Vol 1, No 12: Nodal aggressive non-Hodgkin’s lymphoma in the adult

Vol 1, No 11: Thalidomide in the treatment of multiple myeloma, Sydney, 10 April 2005

Vol 1, No 10: Hemostasis and pregnancy, Milan, November 10, 2005

Vol 1, No 9: 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005

Vol 1, No 8: New Drugs in Hematology, Bologna, October 9-11, 2005

Vol 1, No 7: Fourth International Symposium on Acute Promyelocytic Leukemia, Rome, September 29-October 1, 2005

Vol 1, No 6: Von Willebrand Factor and von Willebrand disease: the state of the art in 2005

Vol 1, No 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005

Vol 1, No 4: Nordic von Willebrand Workshop 2004

Vol 1, No 3: Homocysteine Metabolism. 5th International Conference, Milan, Italy, June 26-30, 2005

Vol 1, No 2: Is Elimination of Minimal Residual Disease Significant for the Outcome of CLL? The Role of Alemtuzumab

1 - 43 of 43 Items

*********************************************************************

Hematology Meeting Reports is ©2005-2010 Ferrata Storti Foundation

© PAGEPress - PAGEPress is a registered trademark property of Medit, Italy. - VAT: IT0212570185